| Micheal Thomas Murphy, MD | |
|
3651 College Blvd, Leawood, KS 66211-1910 | |
| (913) 319-7600 | |
| (913) 253-1702 |
| Full Name | Micheal Thomas Murphy |
|---|---|
| Gender | Male |
| Speciality | Physical Medicine & Rehabilitation |
| Location | 3651 College Blvd, Leawood, Kansas |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1609372648 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208100000X | Physical Medicine & Rehabilitation | 2020032469 (Missouri) | Secondary |
| 208100000X | Physical Medicine & Rehabilitation | 04-47341 (Kansas) | Primary |
| Entity Name | Dickson Diveley Midwest Orthopaedic Clinic Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669421509 PECOS PAC ID: 1153225479 Enrollment ID: O20031119000939 |
News Archive
The rate of health care-associated infections in developing countries is more than three times the rate of cases in the U.S. and more than double the rate in Europe, according to a study published Friday in the Lancet, BBC reports (12/9).
Celera Corporation (NASDAQ:CRA) and Medco Health Solutions, Inc. (NYSE:MHS), today announced that they have entered into a research collaboration to evaluate whether testing for a gene variant called KIF6 increases patient adherence with statin therapy. Current studies have suggested that only about 50 to 60 percent of the patients who receive a prescription for a lipid-lowering drug are taking the medication after six months.
The Royal Society today has contributed little to medical science and should undergo an urgent review of its purpose and programmes, states an editorial in this week's issue of The Lancet.
When bacteria develop antibiotic resistance, treatment with these medications becomes ineffective. Similarly, tumor cells can also change in such a way that renders them resistant to particular medications.
BIOLASE Technology, Inc., the world's leading dental laser company, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its Waterlase MD™ laser system for removal of subgingival calculi to prevent and treat periodontitis, the greatest cause of tooth loss for adults over 35 and a condition impacting more than half of Americans over the age of 55, as reported by the American Academy of Periodontology (AAP).
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Micheal Thomas Murphy, MD 3651 College Blvd, Leawood, KS 66211-1910 Ph: (913) 319-7600 | Micheal Thomas Murphy, MD 3651 College Blvd, Leawood, KS 66211-1910 Ph: (913) 319-7600 |
News Archive
The rate of health care-associated infections in developing countries is more than three times the rate of cases in the U.S. and more than double the rate in Europe, according to a study published Friday in the Lancet, BBC reports (12/9).
Celera Corporation (NASDAQ:CRA) and Medco Health Solutions, Inc. (NYSE:MHS), today announced that they have entered into a research collaboration to evaluate whether testing for a gene variant called KIF6 increases patient adherence with statin therapy. Current studies have suggested that only about 50 to 60 percent of the patients who receive a prescription for a lipid-lowering drug are taking the medication after six months.
The Royal Society today has contributed little to medical science and should undergo an urgent review of its purpose and programmes, states an editorial in this week's issue of The Lancet.
When bacteria develop antibiotic resistance, treatment with these medications becomes ineffective. Similarly, tumor cells can also change in such a way that renders them resistant to particular medications.
BIOLASE Technology, Inc., the world's leading dental laser company, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its Waterlase MD™ laser system for removal of subgingival calculi to prevent and treat periodontitis, the greatest cause of tooth loss for adults over 35 and a condition impacting more than half of Americans over the age of 55, as reported by the American Academy of Periodontology (AAP).
› Verified 5 days ago
Shynda F Miles, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 8800 State Line Rd, Leawood, KS 66206 Phone: 913-383-9099 Fax: 913-213-6026 | |
Dr. Steven Hendler, M.D. Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 11111 Nall Ave, # 222, Leawood, KS 66211 Phone: 913-338-5448 Fax: 913-317-8340 | |
Sadie Schulze Laughlin, DPT Physical Medicine & Rehabilitation Medicare: May Accept Medicare Assignments Practice Location: 9425 Mission Rd, Leawood, KS 66206 Phone: 913-381-2100 Fax: 913-273-1458 | |
Dr. Stephen Nathan Rosenberg, DO Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 4940 W 137th Street, Suite B, Leawood, KS 66224 Phone: 913-424-9670 Fax: 913-851-4430 | |
Dr. Fermin Jose Santos, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 3651 College Blvd, Leawood, KS 66211 Phone: 913-319-7600 Fax: 913-253-1702 | |
Dr. Daniel Byron Sisk, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 3651 College Blvd, Leawood, KS 66211 Phone: 913-319-7600 Fax: 913-253-1702 |